Table 1.
Screen Phase | Considerations | Advantages/Disadvantages |
---|---|---|
I. Targets What genes will be studied? |
Choice of library | • Genome-scale libraries have the benefit of being comprehensive but can be resource-intensive. Predesigned genome-wide CRISPR libraries are available • Targeted libraries focus on class of elements (kinases, transcription factors, etc.) or can be custom-designed and generated by the investigator |
II. Model What cells should be used? |
Cas9 expression | • Primary cells require delivery of both Cas9 and sgRNA, which may be technically challenging • Stably expressing Cas9 cell lines provide uniform high expression of Cas9 |
III. Assay How are cells screened? |
Phenotype | • A classical screen results in positive or negative selection from a selective pressure (e.g., exposure to a drug) • Combining CRISPR screens with other genetic tools such as reporter cell lines can facilitate screening for diverse phenotypes |
IV. Analysis How are screen results evaluated? |
Measuring screen outputs | • Changes in sgRNA abundance, measured by next-generation sequencing, are a classical output of CRISPR-ko screens • A variety of validated CRISPR screen analysis pipelines are publicly available |
Abbreviations: CRISPR-ko, CRISPR knockout; sgRNA, single guide RNA.